At the European Association of Urology Congress in Paris, a recent study was presented unveiling the initial findings of the first long-term follow-up study on the Uromune (MV140) inactivated vaccine developed by the Madrid-based Immunotek S.
Research has found the treatment can prevent urinary tract infections (UTIs) for up to nine years in more than half of patients. The vaccine is given as a pineapple- flavoured oral spray.
Each year UTI infection leads to 150,000 hospitalisations, costing the NHS £380 million annually - during the study the average infection-free period was four and a half years)
9-Year Study Unveils Possible UTI Oral Vaccine Alternative to Antibiotics miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.